2001
Analysis of Risk Factors for Fatal Rocky Mountain Spotted Fever: Evidence for Superiority of Tetracyclines for Therapy
Holman R, Paddock C, Curns A, Krebs J, McQuiston J, Childs J. Analysis of Risk Factors for Fatal Rocky Mountain Spotted Fever: Evidence for Superiority of Tetracyclines for Therapy. The Journal Of Infectious Diseases 2001, 184: 1437-1444. PMID: 11709786, DOI: 10.1086/324372.Peer-Reviewed Original ResearchConceptsRisk factorsFatal Rocky Mountain Spotted FeverRocky Mountain Spotted FeverOnset of symptomsCase fatality rateTetracycline-class antibioticsPrimary therapyClinical characteristicsOlder patientsAppropriate therapyRMSF casesNonfatal casesNational surveillanceHigh riskSpotted FeverPatientsEffective antibioticsTherapyDeathFeverAntibioticsTreatmentSymptomsFactorsDisease
2000
Incidence of Rocky Mountain spotted fever among American Indians in Oklahoma.
McQuiston J, Holman R, Groom A, Kaufman S, Cheek J, Childs J. Incidence of Rocky Mountain spotted fever among American Indians in Oklahoma. Public Health Reports 2000, 115: 469-75. PMID: 11236019, PMCID: PMC1308603, DOI: 10.1093/phr/115.5.469.Peer-Reviewed Original ResearchMeSH KeywordsCenters for Disease Control and Prevention, U.S.Disease NotificationHealth EducationHospitalizationHospitals, FederalHumansIncidenceIndians, North AmericanMedical RecordsOklahomaPopulation SurveillanceRetrospective StudiesRocky Mountain Spotted FeverUnited StatesUnited States Indian Health ServiceConceptsCase report formsIncidence of RMSFAvailable medical chartsHospital discharge databaseReport formsAmerican IndiansHigh incidence rateMajority of casesCase inclusion criteriaClinical suspicionMedical chartsHospitalization ratesDischarge databaseIncidence rateTick biteInclusion criteriaLaboratory confirmationFever casesHigh incidenceAmerican Indian populationsOklahoma residentsDisease controlNational ratesIncidenceIHS hospitals